Biophore India Pharmaceuticals Pvt Ltd
Biophore’s portfolio spread across 30 therapeutic segments, is specialized in development and manufacture of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media.
For updated list of products, send an email to firstname.lastname@example.org
Meet us at
CPhI Worldwide 201724 - 26 October 2017 Messe Frankfurt, Germany Visit us at stand 80H23 Book a meeting See our Exhibitor Profile
Our Top products
DMF filed in February 2017Novel route of synthesisStringent controls on Impurity profile; substantially pure API.US DMF FiledMore info
Permethrin is a first-line treatment for scabies.
Biophore's Permethrin : ASMF Filed, DMF Filed.
25: 75 ratioCEP Filed.
News about Biophore India Pharmaceuticals Pvt Ltd
26 Jan 2017
DCAT 2017 - New York
Meet Biophore Team at the upcoming DCAT Meeting in New York City on March 20th- 23th 2017!Walk-in to our suite in The Kimberly.
17 Nov 2016
Biophore sets up a new central Research & Development laboratory
Biophore, a fast-growing pharmaceutical company involved in development and manufacturing niche generic APIs, sets up a new central Research & Development laboratory in Hyderabad, India. This facility will significantly boost Biophore’ s capabilities a...Read more
11 Aug 2016
Biophore Featured iin Silicon Review's 10 Fastest Growing Pharma companies’ listing 2016
Biophore India Pharmaceuticals Pvt. Ltd has been selected as one of the 10 Fastest Growing Pharma companies list of 2016 in The Silicon Review magazine.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation